Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Peter Rossing(Steno Diabetes Centers), Duncan J. Topliss, Hugo Sanabria, Laura Maffei, Elif I. Ekinci(The University of Melbourne), Mariano Chahin, Elizabeth Vale, George L. Bakris(Pennsylvania State System of Higher Education), Andreas L. Birkenfeld(Helmholtz Zentrum München), Luke Roberts(Bayer (United Kingdom)), Shamasunder Acharya, Gerasimos Filippatos(National and Kapodistrian University of Athens), Eugenia Pedagogos, Richard J. MacIsaac, Luís M. Ruilope(Bayer (Germany)), Federico Pérez Manghi(Centre for Advanced Study), Bertram Pitt(Bayer (Germany)), Walter P. Abhayaratna(Australian National University), Peter G. Colman(The Royal Melbourne Hospital), Diego Besada, Janet B. McGill(Washington University in St. Louis), Diego Aizenberg(University of Glasgow), Gloria Viñes, Inés Bartolacci, Craig Nelson(The University of Melbourne), Alicia Elbert, Chris Ellis, Gary Wittert(South Australian Health and Medical Research Institute), David Packham(The Royal Melbourne Hospital), Michael Suranyi(Liverpool Hospital), Elizabeth Gelersztein, Martin Gebel(Bayer (Germany)), Sylvia E. Rosas(Joslin Diabetes Center), Rajiv Agarwal(Richard L. Roudebush VA Medical Center), Kim Joshua, Simon D. Roger(Gosford Hospital), David Colquhoun, Amer Joseph(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Markus F. Scheerer(Bayer (Germany)), Peak Mann Mah, Julio Bittar(FIND), Alexia Pape, Alberto Liberman, Alfredo Wassermann, Hugo Stephenson, Augusto Vallejos, Paul Regal, Darren Lee(University of Cincinnati Medical Center), Stefan D. Anker(Bayer (Germany))
Cited by 207
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k